Literature DB >> 24857368

Serum tumor markers in bile duct cancer--a review.

M Grunnet1, M Mau-Sørensen.   

Abstract

CONTEXT: Bile duct cancer (BDC) is a disease with a very grave prognosis, often diagnosed too late.
OBJECTIVE: The aim of this review is to evaluate available literature on tumor markers in serum from patients with BDC.
METHODS: Using the search words "serum markers", "bile duct cancer", "cholangiocarcinoma", "biomarker" and "tumor marker", a search was carried out.
RESULTS: Seventy-five studies were included in the review.
CONCLUSION: CA19-9 is by far the most studied and most promising diagnostic and/or prognostic marker in BDC. But also the different mucins are interesting as new markers of BDC in serum.

Entities:  

Keywords:  Bile duct cancer; biomarker; cholangiocarcinoma; diagnosis; prognosis; serum

Mesh:

Substances:

Year:  2014        PMID: 24857368     DOI: 10.3109/1354750X.2014.923048

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  15 in total

1.  Methylation of Tumor Suppressive miRNAs in Plasma from Patients With Pancreaticobiliary Diseases.

Authors:  Koushiro Ohtsubo; Kunio Miyake; Sachiko Arai; Koji Fukuda; Chiaki Suzuki; Hiroshi Kotani; Azusa Tanimoto; Akihiro Nishiyama; Shigeki Nanjo; Kaname Yamashita; Shinji Takeuchi; Seiji Yano
Journal:  Cancer Diagn Progn       Date:  2022-05-03

2.  Therapeutic Monitoring of Circulating DNA Mutations in Metastatic Cancer with Personalized Digital PCR.

Authors:  Christina M Wood-Bouwens; Derrick Haslem; Bryce Moulton; Alison F Almeda; Hojoon Lee; Gregory M Heestand; Lincoln D Nadauld; Hanlee P Ji
Journal:  J Mol Diagn       Date:  2019-12-16       Impact factor: 5.568

3.  Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases.

Authors:  Marut Laohaviroj; Yaovalux Chamgramol; Chawalit Pairojkul; Jason Mulvenna; Banchob Sripa
Journal:  Asian Pac J Cancer Prev       Date:  2016

4.  The Prognostic Value of the CA19-9/TBIL Ratio in Patients with Biliary Tract Cancers (BTCs): A Retrospective Study.

Authors:  Jianchun Xiao; Li Wang; Tao Hong; Binglu Li; Wei Liu; Qiang Qu; Chaoji Zheng; Xiaodong He
Journal:  J Oncol       Date:  2021-02-23       Impact factor: 4.375

5.  Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.

Authors:  Juan W Valle; Harpreet Wasan; Andre Lopes; Alison C Backen; Daniel H Palmer; Karen Morris; Marian Duggan; David Cunningham; D Alan Anthoney; Pippa Corrie; Srinivasan Madhusudan; Anthony Maraveyas; Paul J Ross; Justin S Waters; Will P Steward; Charlotte Rees; Sandy Beare; Caroline Dive; John A Bridgewater
Journal:  Lancet Oncol       Date:  2015-07-12       Impact factor: 41.316

6.  MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract Cancers.

Authors:  Jaihwan Kim; Ji Kon Ryu; Sang Hyub Lee; Yong-Tae Kim
Journal:  Gut Liver       Date:  2016-09-15       Impact factor: 4.519

7.  Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy.

Authors:  Jae Woo Lee; Yong-Tae Kim; Sang Hyub Lee; Jun Hyuk Son; Jin Woo Kang; Ji Kon Ryu; Dong Kee Jang; Woo Hyun Paik; Ban Seok Lee
Journal:  Gut Liver       Date:  2018-01-15       Impact factor: 4.519

Review 8.  Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience.

Authors:  F Rassam; E Roos; K P van Lienden; J E van Hooft; H J Klümpen; G van Tienhoven; R J Bennink; M R Engelbrecht; A Schoorlemmer; U H W Beuers; J Verheij; M G Besselink; O R Busch; T M van Gulik
Journal:  Langenbecks Arch Surg       Date:  2018-01-19       Impact factor: 3.445

9.  Combination of CA19-9 and the Neutrophil-to-Lymphocyte Ratio for the Differential Diagnosis of Gallbladder Carcinoma.

Authors:  Zeyang Chen; Zining Liu; Yuyang Zhang; Pengyuan Wang; Hongqiao Gao
Journal:  Cancer Manag Res       Date:  2020-06-12       Impact factor: 3.989

10.  Persistent Elevation of CA 19-9 Levels in the Long-term Follow-up before Laryngeal Cancer.

Authors:  Hasan Özkan; Fatih Karakaya; Zihni Karaeren; Sibel Perçinel
Journal:  Euroasian J Hepatogastroenterol       Date:  2017-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.